Stay updated with breaking news from Time Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Since the FDA approval in January this year, ophthalmologists have been very optimistic about their intended use of Genentech's Vabysmo...
/PRNewswire/ -- The European regulatory authorities tend to be moving in a different direction than U.S. Food and Drug Administration (FDA) regarding novel...
/PRNewswire/ -- Following an eventful 2021 that included the launch of two new brands—Novartis' Kesimpta and BMS' Zeposia—and generic versions of Biogen's...
/PRNewswire/ -- Spherix Global Insights, a leading market intelligence firm specializing in neurology-based research and insights, has been tracking the...
/PRNewswire/ -- Nephrologists have historically had few options to help slow the progression of kidney disease in their patients – both those with and without...